Cardiovascular Disease and Lipoproteins: Available Evidence and Remaining Questions. Reactor Panel and Open Forum

Value in Health

Volumn 1, Issue 2, 1998, Pages 125-130

  Sanford Schwartz, J ^a   Virgil Brown, W ^b   Hlatky, Mark ^c   Castelli, William ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EMORY UNIVERSITY   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Framingham Cardiovascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013565099     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.1998.120125.x     Document Type: Conference Paper

References (11)

1. Glasziou PP, Simes RJ, Hall J. Design of a cost-effectiveness study within a randomized trial: the LIPID trial for secondary prevention of IHD. Long-term intervention with pravastatin in ischemic heart disease. Control Clin Trials 1997; 18:464-76.
2. Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007-12.
3. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
5. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
6. The Post-Coronary Artery Bypass Craft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Engl J Med 1997;336:153-62.
7. Ornish D, Brown SE, Scherwitz LW, et al. Can life-style changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336:129-33.
8. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992;339:563-9.
9. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988;8:737-41.
10. Gould KL. Myocardial perfusion after cholesterol lowering. J Atherosclerosis Thrombosis 1996;3(2):59-61.
11. Joint National Commission on High Blood Pressure Control. The sixth report of the Joint National Commission on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157(21):2413-46.